Skip to content
value.today

Intelomed, Inc.

Total raised
$11 M
4 rounds on record
Latest round
$2 M
Jan 2016
First round on record
May 2011
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Intelomed, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2016$2 MNo. 4Under $2 million

Intelomed, Inc.: Raise no. 4, Jan 2016

Investors in this round

8 investors had bought by the notice of Jan 29, 2016: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jan Berkow · Executive Officer, Director
  • Jill F. Schiaparelli · Executive Officer, Director
  • Michael Stephen Dignazio · Executive Officer
  • Mark P. Rossi · Director
  • Mary Del Brady · Director
  • R. Stephen Doyle · Director
  • William P. Malloy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The intended total offering amount is up to $5,000,000 with multiple closing dates scheduled to occur.”

Signed by Jill F. Schiaparelli, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jan 29, 2016. Read the notice at the SEC.

equitySEC
Jul 2014$4 MNo. 3$2 to $10 million

Intelomed, Inc.: Raise no. 3, Jul 2014

Investors in this round

29 investors had bought by the notice of Jul 23, 2014: 29 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$25,200
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank J Amoruso · Executive Officer, Director
  • James Sweeney · Director
  • Jan Berkow · Director, Promoter
  • John Moran · Director
  • Mark P. Rossi · Director
  • MaryDel Brady · Director
  • William P. Malloy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank J. Amoruso, President and CEO. Source: SEC Form D, newest notice filed Jul 23, 2014. Read the notice at the SEC.

equitySEC
Sep 2013$2 MNo. 2$2 to $10 million

Intelomed, Inc.: Raise no. 2, Sep 2013

Investors in this round

22 investors had bought by the notice of Sep 10, 2013: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $0 M still to sell
Smallest investment taken
$23,580
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank J Amoruso · Executive Officer, Director
  • James Sweeney · Director
  • Jan Berkow · Director, Promoter
  • John Moran · Director
  • Mark P. Rossi · Director
  • MaryDel Brady · Director
  • William P. Malloy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank J. Amoruso, President and CEO. Source: SEC Form D, newest notice filed Sep 10, 2013. Read the notice at the SEC.

equitySEC
May 2011$3 MNo. 1$2 to $10 million

Intelomed, Inc.: Raise no. 1, May 2011

Investors in this round

15 investors had bought by the notice of May 24, 2011: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$56,760 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frank J Amoruso · Executive Officer
  • Mary Del Brady · Executive Officer, Director
  • James Sweeney · Director
  • Jan Berkow · Director, Promoter
  • John Moran · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Of Total Offering Amt, approx. $2,000,000 of securities offered will be issued for cash, remaining amt. represents the dollar amt of securities(i) being issued pursuant to the conversion of outstanding conv. debt and (ii)reserved for issuance of warrants.”

Signed by Frank J. Amoruso, Ceo. Source: SEC Form D, newest notice filed May 24, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Intelomed, Inc. reported revenue of $33,203 for its most recent fiscal year (filed Oct 2022), up from $14,150 the year before.

    SEC Form C · Oct 2022

  • The direct cost of what it sold was $3,752, so 89% of its revenue was left after those costs.

    SEC Form C · Oct 2022

  • Net loss for the same year: $1.27 million.

    SEC Form C · Oct 2022

  • Intelomed, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2016).

    SEC Form D · Jan 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2016

Products and services#

No products or services on record: the address on record now leads to another company's site.

Investors#

No investor of Intelomed, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 29 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Intelomed, Inc.
NameRoleNamed in
Jan BerkowExecutive officerJan 2016
Jill F. SchiaparelliExecutive officerJan 2016
Michael Stephen DignazioExecutive officerJan 2016
Frank J AmorusoExecutive officerJul 2014
Mary Del BradyExecutive officerMay 2011
Jan BerkowDirectorJan 2016
Jill F. SchiaparelliDirectorJan 2016
Mark P. RossiDirectorJan 2016
Mary Del BradyDirectorJan 2016
R. Stephen DoyleDirectorJan 2016
William P. MalloyDirectorJan 2016
Frank J AmorusoDirectorJul 2014
James SweeneyDirectorJul 2014
John MoranDirectorJul 2014
MaryDel BradyDirectorJul 2014
Jan BerkowPromoterJul 2014